Ibrutinib (Imbruvica) and Ketamine Therapy | Tovani Health
Imbruvica (Ibrutinib) — BTK inhibitor (CLL, MCL, Waldenström macroglobulinemia, cGVHD)
Verdict at Tovani Health
Fully compatible; hemorrhage and atrial fibrillation risks are intrinsic to ibrutinib.
Ibrutinib and ketamine have no direct clinically significant interaction. First-in-class BTK inhibitor, dramatically effective in CLL and several other B-cell malignancies. The intrinsic safety considerations worth knowing about — increased bleeding risk (especially with anticoagulants and antiplatelets), new-onset or worsened atrial fibrillation, and ventricular arrhythmias — are ibrutinib-class concerns independent of KAP. Ibrutinib is also a CYP3A4 substrate, so strong inhibitors raise its level and toxicity (an ibrutinib dose conversation, not KAP).
If you take Imbruvica regularly and are considering at-home ketamine therapy, the combination is generally safe at therapeutic doses. This page covers the brief pharmacologic context and what we do at intake.
How Imbruvica interacts with ketamine
Ibrutinib irreversibly inhibits Bruton's tyrosine kinase, blocking B-cell receptor signaling. CYP3A4 substrate with no inhibitor or inducer activity relevant to ketamine.
What we do at intake
Continue as prescribed. Tell us about any bleeding events, AFib, or cardiac symptoms.
Bottom line
Ibrutinib and ketamine have no direct clinically significant interaction. First-in-class BTK inhibitor, dramatically effective in CLL and several other B-cell malignancies. The intrinsic safety considerations worth knowing about — increased bleeding risk (especially with anticoagulants and antiplatelets), new-onset or worsened atrial fibrillation, and ventricular arrhythmias — are ibrutinib-class concerns independent of KAP. Ibrutinib is also a CYP3A4 substrate, so strong inhibitors raise its level and toxicity (an ibrutinib dose conversation, not KAP).
Ready to find out if at-home ketamine fits your situation?
We’ll note that you’re on Imbruvica (Ibrutinib) at intake. The eligibility check takes 5 minutes and gives you an honest answer about whether at-home ketamine fits your specific situation.
FL and NJ residents only. Benjamin Soffer, DO — Tovani Health.
Clinically reviewed
Reviewed by Benjamin Soffer, DO on May 22, 2026. Dr. Soffer is a board-certified physician (American Board of Internal Medicine) licensed in Florida and New Jersey, prescribing at-home ketamine therapy through Tovani Health.
This page is general information about how this medication interacts with at-home ketamine therapy at Tovani Health. It is not a substitute for medical advice from your prescribing physician about your specific situation. Always discuss medication changes with the doctor who prescribed them.